Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$72.62 - $79.98 $221,708 - $244,178
-3,053 Closed
0 $0
Q1 2022

Apr 14, 2022

SELL
$61.48 - $73.72 $4,119 - $4,939
-67 Reduced 2.15%
3,053 $223,000
Q4 2021

Jan 14, 2022

BUY
$53.63 - $62.52 $107 - $125
2 Added 0.06%
3,120 $195,000
Q3 2021

Oct 13, 2021

BUY
$59.17 - $69.31 $1,834 - $2,148
31 Added 1.0%
3,118 $184,000
Q2 2021

Jul 23, 2021

SELL
$61.91 - $67.42 $14,734 - $16,045
-238 Reduced 7.16%
3,087 $207,000
Q1 2021

Apr 09, 2021

SELL
$59.34 - $66.74 $35,544 - $39,977
-599 Reduced 15.27%
3,325 $210,000
Q4 2020

Jan 19, 2021

SELL
$57.74 - $65.43 $17,206 - $19,498
-298 Reduced 7.06%
3,924 $243,000
Q3 2020

Oct 21, 2020

BUY
$57.43 - $63.64 $114 - $127
2 Added 0.05%
4,222 $255,000
Q2 2020

Aug 03, 2020

BUY
$54.82 - $64.09 $109 - $128
2 Added 0.05%
4,220 $248,000
Q1 2020

Apr 20, 2020

SELL
$46.4 - $67.43 $20,648 - $30,006
-445 Reduced 9.54%
4,218 $236,000
Q4 2019

Jan 29, 2020

SELL
$49.21 - $64.19 $73,667 - $96,092
-1,497 Reduced 24.3%
4,663 $299,000
Q3 2019

Oct 21, 2019

SELL
$42.77 - $50.71 $164,536 - $195,081
-3,847 Reduced 38.44%
6,160 $312,000
Q2 2019

Jul 15, 2019

BUY
$44.62 - $49.34 $305,959 - $338,324
6,857 Added 217.68%
10,007 $452,000
Q1 2019

Apr 11, 2019

BUY
$45.12 - $53.8 $142,128 - $169,470
3,150 New
3,150 $150,000
Q4 2018

Jan 11, 2019

SELL
$48.76 - $63.23 $3,413 - $4,426
-70 Closed
0 $0
Q3 2018

Oct 22, 2018

SELL
$55.19 - $62.25 $17,108 - $19,297
-310 Reduced 81.58%
70 $4,000
Q2 2018

Jul 17, 2018

BUY
$50.53 - $62.98 $5,305 - $6,612
105 Added 38.18%
380 $21,000
Q1 2018

Apr 05, 2018

SELL
$59.92 - $68.98 $29,660 - $34,145
-495 Reduced 64.29%
275 $17,000
Q3 2017

Oct 19, 2017

BUY
$55.23 - $63.74 $42,527 - $49,079
770
770 $49,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Edge Wealth Management LLC Portfolio

Follow Edge Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Wealth Management LLC with notifications on news.